Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 10: AMD III Session

Date/Time: | Room:

Back to Previous

Title

Theme

14:30:00 S. Razavi France Predictive analysis of the 12week dosing status at week 48 for patients receiving brolucizumab in the HAWK and HARRIER studies
14:36:00 I. Westborg Sweden Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet AMD: Realworld data from the INSIGHT study in the Swedish macula register
14:42:00 M. Gillies Australia Prevalence and characteristics of geographic atrophy in eyes with neovascular agerelated macular degeneration treated with vascular endothelial growth factor inhibitors
14:48:00 E. Fletcher Australia Positive cellular effects induced by the nanosecond laser in the mouse and human posterior eye
14:54:00 K. Kataoka Japan Followup of type 3 neovascularization with Bscan flow optical coherence tomography angiography
15:00:00 R. Schwartz United Kingdom OCTA may be used as a clinical decision tool to determine treatment interval in treat and extend regimen in choroidal neovascularization secondary to agerelated macular degeneration
15:06:00 D. Ahmed Austria Relationship between drusen characteristics and type 2 macular neovascularization in agerelated macular degeneration
15:12:00 A. Tufail, J. S. Heier United Kingdom Lampalizumab for geographic atrophy secondary to agerelated macular degeneration: Pooled results of the chroma and spectri phase 3 randomized clinical trials
15:18:00 B. Gerendas Austria Imaging biomarkers predictive for visual acuity in neovascular agerelated macular degeneration
15:24:00 P. Mitchell Australia Intravitreal aflibercept with and without rescue photodynamic therapy in polypoidal choroidal vasculopathy: 2year results of the PLANET study
15:30:00 A. Burés Jelstrup Spain Phase IV study to evaluate genetic variants of VEGF pathway as biomarkers of VEGF TrapEye treatment efficacy in subjects with neovascular agerelated macular degeneration (wAMD). 104 weeks results. BIOIMAGE Study
15:36:00 R. Aydin United States Increased intraaretinal radial reflectance (retinal flare) as an optical coherence tomographic coherence tomographic biomarker for the diagnosis of retinal angiomatous proliferation
15:42:00 M. Schmid Switzerland Testretest reliability and diagnostic accuracy of Alleye, a patient selftest for the detection of wet agerelated macular degeneration
15:48:00 A. Rajendran India Genetic risk factors influencing late agerelated macular degeneration in India

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved